| Literature DB >> 26060676 |
Muhammad Sadik Memon1, Shamsuddin Solangi2, Shabana Lakho1, Zain Islam Arain2, Farukh Naz2, Madiha Zaki2.
Abstract
BACKGROUND: Malaria is the second most frequent clinically suspected disease entity after acute respiratory tract infection in developing countries. Active malarial transmission occurs throughout the year, while aggressive out bursts of disease are seen mainly during and after the 'monsoon' season. This study aimed to determine the morbidity and mortality associated with malaria during flood at Isra University Hospital, Hyderabad.Entities:
Keywords: Disease burden; Flood; Malaria; Monsoon
Year: 2014 PMID: 26060676 PMCID: PMC4454037
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Co-morbid and its relation with disease outcome
| Variables | Improved & discharged (n=60) | Died (n=14) | Total (n=74) | P-Value | OR (95% C.I) |
|---|---|---|---|---|---|
| Yes | 3 (5) | 5 (35.7) | 8 (10.8) | 0.005* | 1.24(1.1 - 1.3) |
| No | 57 (95) | 9 (64.2) | 66 (89.2) | ||
| Yes | 7(11.7) | 1(7.1) | 8(10.8) | 0.62 | 1.71(0.1 – 15.2) |
| No | 53(88.3) | 13(92.9) | 66(89.2) | ||
| Yes | 3(5.0) | 1(7.1) | 4(5.4) | 0.57 | 0.68(0.06 – 1.11) |
| No | 57(95.0) | 13(92.9) | 70(94.6) | ||
| Yes | 2(3.3) | 0 | 2(2.7) | 0.48 | 1.24(1.1 – 1.3) |
| No | 58(96.7) | 14(100) | 72(97.3) | ||
| (+ve) | 2(3.3) | 0 | 2(2.7) | 0.99 | 1.2(1.1 – 1.3) |
| (-ve) | 58(96.7) | 14(100) | 72(97.3) | ||
| (+ve) | 6(10) | 1(7.1) | 7(9.5) | 0.74 | 1.4(0.1 – 13.0) |
| (-ve) | 54(90) | 13(92.9) | 67(90.5) | ||
| Yes | 2(3.3) | 0 | 2(2.7) | 0.98 | 1.24(1.1 – 1.3) |
| No | 58(96.7) | 14(100) | 72(97.3) |
Association of clinical and biochemical data with disease outcome
| Variables | Improved & discharged Mean ± SD | Died Mean ± SD | Overall | P-Value |
|---|---|---|---|---|
| Temperature - °F | 100.57 ± 2.09 | 100.9 ± 1.49 | 100.6 ± 1.99 | 0.55 |
| Platelets-mm3 | 109.7 ± 91.22 | 104.2 ± 57.14 | 108.6 ± 85.50 | 0.83 |
| Total Bilirubin-mg/dl | 4.28 ± 7.70 | 7.14 ± 10.20 | 4.82 ± 8.23 | 0.24 |
| RBS-mg/dl* | 111.6 ± 68.07 | 126 ± 99.64 | 114.3 ± 74.47 | 0.51 |
| Hemoglobin-g/dl | 9.20 ± 2.97 | 8.04 ± 3.45 | 8.98 ± 3.08 | 0.2 |
| WBC-mm3† | 8.21 ± 7.80 | 9.64 ± 6.08 | 8.48 ± 7.49 | 0.52 |
| SGPT‡ | 50.28 ± 74.66 | 56.78 ± 39.92 | 51.51 ± 69.25 | 0.75 |
| Sodium | 136.3 ± 6.50 | 139.2 ± 8.05 | 136.8 ± 6.85 | 0.15 |
| Creatinine-mg/dl | 1.33 ± 1.05 | 4.12 ± 4.19 | 1.86 ± 2.28 | <0.001 |
| Hospital-Days | 4.9 ± 1.68 | 3.6 ± 1.69 | 4.6 ± 1.74 | 0.01* |
Association of clinical manifestations with disease outcome
| Variables | Improved & discharged (n=60) | Died (n=14) | Total (n=74) | P-Value | OR (95% C.I) | |
|---|---|---|---|---|---|---|
| Yes | 14(23.3) | 3(21.4) | 17(23.0) | 0.97 | 1.1(0.2 – 4.5) | |
| No | 46(76.7) | 11(78.6) | 57(77.0) | |||
| Yes | 8(13.3) | 2(14.3) | 10(13.5) | 0.99 | 0.9(0.1 – 4.9) | |
| No | 52(86.7) | 12(85.7) | 64(86.5) | |||
| Yes | 8(13.3) | 5(35.7) | 13(17.6) | 0.05* | 0.27(0.07 – 1.0) | |
| No | 52(86.7) | 9(64.3) | 61(82.4) | |||
| Yes | 2(3.3) | 8(57.1) | 10(13.5) | <0.001* | 0.02(0.004 – 1.5) | |
| No | 58(96.7) | 6(42.9) | 64(86.5) | |||
| Yes | 1(1.7) | 8(57.1) | 9(12.2) | <0.001* | 0.01(0.001 – 0.1) | |
| No | 59(98.3) | 6(42.9) | 65(87.8) |
Complications and its association with disease outcome
| Variables | Improved & discharged (n=60) | Died (n=14) | Total (n=74) | P-Value | OR (95% C.I) | |
|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | ||||
| Yes | 19(31.7) | 7(50.0) | 26(35.1) | 0.22 | 0.46(0.1 – 1.5) | |
| No | 41(68.3) | 7(50.0) | 48(64.9) | |||
| Yes | 17(28.3) | 7(50.0) | 24(32.4) | 0.2 | 0.39(0.1 – 1.2) | |
| No | 43(71.7) | 7(50.0) | 50(67.6) | |||
| Yes | 4(6.7) | 3(21.4) | 7(9.5) | 0.12 | 0.26(0.05 – 1.3) | |
| No | 56(93.3) | 11(78.6) | 67(90.5) | |||
| Yes | 2(3.3) | 3(21.4) | 5(6.8) | 0.04* | 0.12(0.01 – 1.3) | |
| No | 58(96.7) | 11(78.6) | 69(93.2) | |||
| Yes | 13(21.7) | 7(50.0) | 20(27.0) | 0.04* | 0.2(0.08 – 0.9) | |
| No | 47(78.3) | 7(50.0) | 54(73.0) | |||
| Yes | 14(23.3) | 10(71.4) | 24(32.4) | 0.001* | 0.12(0.03 – 0.4) | |
| No | 46(76.7) | 4(28.6) | 50(67.6) | |||
| Yes | 11(18.3) | 9(64.3) | 20(27.0) | 0.001* | 0.12(0.03 – 0.4) | |
| No | 49(81.7) | 5(35.7) | 54(73.0) |